Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2003-04-03 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ARMENTIERES (59280), Nord
PHARMACIE BOUTON : revenue, balance sheet and financial ratios
PHARMACIE BOUTON is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ARMENTIERES (59280),
this company of category PME
shows in 2024 a revenue of 3.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BOUTON (SIREN 448122614)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
3 770 313 €
3 711 336 €
4 089 020 €
3 368 020 €
N/C
2 449 624 €
2 392 705 €
2 362 134 €
N/C
Net income
180 209 €
169 958 €
210 984 €
496 467 €
319 886 €
114 583 €
101 706 €
117 125 €
117 744 €
46 857 €
EBITDA
N/C
281 401 €
348 764 €
745 355 €
455 511 €
N/C
142 623 €
160 178 €
180 653 €
N/C
Net margin
N/C
4.5%
5.7%
12.1%
9.5%
N/C
4.2%
4.9%
5.0%
N/C
Revenue and income statement
In 2025, PHARMACIE BOUTON generates positive net income of 180 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 47 k€ -> 180 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
180 209 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
50.535%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
56.967%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
29.367
23.785
35.536
34.799
110.705
91.191
69.227
57.784
51.282
50.535
Financial autonomy
67.226
68.775
64.38
63.961
40.893
46.177
51.521
55.958
59.084
56.967
Repayment capacity
None
2.633
3.958
3.656
None
4.181
2.396
4.845
4.776
None
Cash flow / Revenue
None%
5.367%
5.394%
5.194%
None%
10.037%
12.621%
6.064%
5.498%
None%
Sector positioning
Debt ratio
50.532025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+5 pts over 3 years
In 2025, the debt ratio of PHARMACIE BOUTON (50.53) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
56.97%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good-5 pts over 3 years
In 2025, the financial autonomy of PHARMACIE BOUTON (57.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.78 years2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Average
In 2024, the repayment capacity of PHARMACIE BOUTON (4.78) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 149.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
149.259
Liquidity indicators evolution PHARMACIE BOUTON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
140.644
164.443
176.742
133.521
143.924
170.007
179.411
178.471
183.076
149.259
Interest coverage
None
2.0
2.164
3.263
None
1.44
0.74
1.782
3.123
None
Sector positioning
Liquidity ratio
149.262025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average-11 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE BOUTON (149.26) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
3.12x2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Good+14 pts over 2 years
In 2024, the interest coverage of PHARMACIE BOUTON (3.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE BOUTON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
273 157 €
369 051 €
347 651 €
0 €
248 021 €
202 447 €
300 989 €
362 402 €
0 €
Inventory turnover (days)
0
43
47
38
0
30
26
27
28
0
Customer payment term (days)
0
7
11
12
0
9
7
9
9
0
Supplier payment term (days)
0
45
46
49
0
35
31
33
34
0
Positioning of PHARMACIE BOUTON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE BOUTON is estimated at
2 862 641 €
(range 1 942 601€ - 4 491 878€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1942k€2862k€4491k€
2 862 641 €Range: 1 942 601€ - 4 491 878€
NAF 5 année 2025
Valuation method used
Net Income Multiple
180 209 €
×
15.9x
=2 862 641 €
Range: 1 942 602€ - 4 491 879€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BOUTON with other companies in the same sector:
The revenue of PHARMACIE BOUTON in 2024 is 3.8 M€.
Is PHARMACIE BOUTON profitable?
Yes, PHARMACIE BOUTON generated a net profit of 180 k€ in 2025.
Where is the headquarters of PHARMACIE BOUTON ?
The headquarters of PHARMACIE BOUTON is located in ARMENTIERES (59280), in the department Nord.
Where to find the tax return of PHARMACIE BOUTON ?
The tax return of PHARMACIE BOUTON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BOUTON operate?
PHARMACIE BOUTON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart